編號,通報時間,中文品名,英文品名,許可證字號,成分學名,劑型劑量,許可證持有藥商,短缺原因,評估結果及建議
"1","20161115","癌康定膠囊1毫克","HYCAMTIN CAPSULES 1MG","衛署藥輸字第025245號","TOPOTECAN HYDROCHLORIDE","1mg/cap","台灣諾華股份有限公司","原料短缺","無同成分藥品可以替代於臨床應用，可能產生藥品短缺"
"2","20160920","無","Imukin","","Interferon gamma-1b","0.1mg/0.5ml/vial","台灣百靈佳殷格翰股份有限公司","藥證相關問題或代理權變更","無替代品項"
"3","20160829","天乾甘油溶液８５％","GLYCERIN SOLUTION 85% ＂TK＂","衛署成製字第008674號","GLYCERIN (eq to GLYCEROL)","外用液劑","天乾製藥有限公司","與PIC/S相關","GLYCERIN的主要作用為保濕，使皮膚感覺較滋潤不會有緊繃乾澀感，亦可以作為抗凍劑，主要用途大多為外用製劑，目前生產GLYCERIN作為皮膚外用製劑者皆無藥證，其他GLYCERIN製劑有藥證且能供貨者皆是作為瀉下劑使用(濃度10~50%; 人生製藥、大法貿易)。建議主管機關協調或輔導有原料藥藥證之廠商生產高濃度之GLYCERIN，以供臨床使用。"
"4","20160829","美必定注射液","BIPIDEN INJECTION","衛署藥製字第044187號","BIPERIDEN","5mg/ml","壽元化學工業股份有限公司","廠商停產","1. 目前國內生產BIPERIDEN針劑劑型之藥廠只有壽元化學工業股份有限公司，且因壽元化學將停產此藥品。 2. 根據同ATC code 前5碼之藥品，台灣目前亦無針劑劑型之許可證。 3. 針劑劑型之BIPERIDEN臨床上主要用於acute drug-induced dystonic reaction與Parkinsonism。 4. Acute drug-induced dystonic reaction替代用藥為: Diphenhydramine HCl or BZDs，但無法完全取代BIPERIDEN 5. 若需Anticholinergic 之針劑劑型藥品，只能專案進口。"
"5","20160728","葡萄糖酸鈣注射液１０％","CALCIUM GLUCONATE INJECTION 10% ＂C.C.P.C.＂","衛署藥製字第038229號","CALCIUM GLUCONATE","注射劑","中國化學製藥股份有限公司新豐工廠","廠商停產","同成份、不同劑型、不同劑量之口服CALCIUM GLUCONATE可供替代(HOSHIZO CALCIUM TABLET - 德佑藥品有限公司代理進口)，臨床如需使用注射劑型藥物作為鈣的補充劑，可使用不同成份、同劑型之Calcium Chloride替代( VITACAL INJECTION ，信東)。根據Injectable drugs 相容性資料，全靜脈營養注射鈣補充建議使用Calcium gluconate，Calcium chloride沒有全靜脈營養注射相容性相關資料，基於安全考量，使用全靜脈營養注射之鈣補充建議專案進口Calcium gluconate。"
"6","20160323","促甲狀腺激素釋放荷爾蒙注射液〝田邊〞","TRH INJECTION ＂TANABE＂/PROTIRELIN","","TRH INJECTION ＂TANABE＂/PROTIRELIN","注射劑","台田藥品股份有限公司","與PIC/S相關","此藥品為診斷型用藥，臨床無類似可替代藥物。建議以專案進口TRH製劑供臨床使用。"
